Maximizing the dual benefit of pet dogs in cancer trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39891026.
- Also identified by DOI 10.1038/s41568-025-00792-0 and PMC identifier 11867848.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pet dogs with cancer have catalysed the translation of preclinical discoveries to first-in-human trials, highlighting the unique power of comparative oncology to study veterinary and human patients with cancer in parallel. However, the full potential of this approach has yet to be harnessed. Here we highlight accomplishments in oncology due to trials in dogs and discuss the next steps to advance comparative oncology.